EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neutralization of Rubella Vaccine Virus and Immunodeficiency-Related Vaccine-Derived Rubella Viruses by Intravenous Immunoglobulins

Min-Hsin Chen, Ludmila Perelygina iD, LiJuan Hao, R Suzanne Beard, Cornelia Lackner iD, Maria R Farcet iD, Michael Karbiener iD, Joseph Icenogle, Thomas R Kreil iD

The Journal of Infectious Diseases · 2024

DOI: 10.1093/infdis/jiae182 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Min-Hsin Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Viral Vaccine Preventable Diseases Branch, National Center for Immunization & Respiratory Diseases, Centers for Disease Control and Prevention, Atlan…. Hauptthemen laut MEDLINE: Rubella virus, Rubella Vaccine, Immunoglobulins, Intravenous, Rubella. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Takeda Manufacturing Austria.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The association between granulomas and vaccine-derived rubella virus (VDRV) in people with primary immunodeficiencies has raised concerns about the ability of immunoglobulin preparations to neutralize VDRVs. We investigated the capacity of immunoglobulin to neutralize rubella vaccine virus and 4 VDRV strains. As expected, the rubella vaccine virus itself was potently neutralized by immunoglobulin preparations, but the VDRV isolates from patients after intrahost evolution, 2–6 times less so. Diagnosis of immune deficiencies before possible live-virus vaccination is thus of critical importance, while immunoglobulin replacement therapy can be expected to provide protection from rubella virus infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rubella virusRubella VaccineImmunoglobulins, IntravenousRubellaHumansAntibodies, NeutralizingAntibodies, ViralNeutralization Tests

Stichwörter der Autor:innen

immunodeficiencyimmunodeficiency-related rubella vaccine-derived mutantsintravenous immune globulinrubella virusvirus neutralization

Substanzen

Rubella VaccineImmunoglobulins, IntravenousAntibodies, NeutralizingAntibodies, Viral

Autor:innen und Institutionen

  • Viral Vaccine Preventable Diseases Branch, National Center for Immunization & Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Global Pathogen Safety, Takeda Manufacturing Austria AG, Vienna, Austria.

ORCID-Profile: Ludmila Perelygina, Cornelia Lackner, Maria R Farcet, Michael Karbiener, Thomas R Kreil

Förderung

  • Takeda Manufacturing Austria

Zitieren

APA

Chen, M. H., Perelygina, L., Hao, L., Beard, R. S., Lackner, C., Farcet, M. R., Karbiener, M., Icenogle, J., & Kreil, T. R. (2024). Neutralization of Rubella Vaccine Virus and Immunodeficiency-Related Vaccine-Derived Rubella Viruses by Intravenous Immunoglobulins. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae182

Vancouver

Chen MH, Perelygina L, Hao L, Beard RS, Lackner C, Farcet MR, et al. Neutralization of Rubella Vaccine Virus and Immunodeficiency-Related Vaccine-Derived Rubella Viruses by Intravenous Immunoglobulins. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiae182

BibTeX
@article{Chen2024,
  author = {Chen, Min-Hsin and Perelygina, Ludmila and Hao, LiJuan and Beard, R Suzanne and Lackner, Cornelia and Farcet, Maria R and Karbiener, Michael and Icenogle, Joseph and Kreil, Thomas R},
  title = {Neutralization of Rubella Vaccine Virus and Immunodeficiency-Related Vaccine-Derived Rubella Viruses by Intravenous Immunoglobulins},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  doi = {10.1093/infdis/jiae182}
}
Kostenlos starten →